Purchase Order HHSN261201000601P

<p>This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Studylog Systems, Inc., a self-certified small disadvantaged business. The contract is for a STUDY DIRECTOR ONCOLOGY V2.1 PERPETUAL LICENSE, item #SD-ONC, with a ceiling value of $8,200. The award was made on September 21, 2012, with a completion date of September 28, 2012. The contract does not have a set-aside designation.</p>

This is a firm fixed-price purchase order contract awarded by the Defense Health Agency (DHA) to Onco Inc., a woman-owned small business, for the provision of ONCOLOG software licenses. The contract has a total ceiling value of $2,830,154.41 and a period of performance extending to September 29, 2028. Onco Inc. is a New Jersey-based company that specializes in oncology-related software solutions and healthcare data management services for federal healthcare agencies. The contract does not have a...

This is a firm fixed price purchase order awarded by the Food and Drug Administration (FDA) to Life Technologies Corporation, a manufacturer of scientific instruments, reagents, and consumables. The contract has a ceiling value of $3,440.90 and a completion date of July 6, 2011. The contract is for &quot;TAS::75 0600::TAS SFM MEDIUM&quot; and does not have a set-aside designation. Life Technologies Corporation serves as a prime contractor across various federal agencies, including the National...

This is a delivery order contract awarded by the Food and Drug Administration (FDA) to Lovelace Biomedical and Environmental Research Institute, Inc. (LBERI), a non-profit research organization, to develop a standard guideline protocol for rodent tobacco smoke inhalation studies. The contract has a ceiling value of $1,373,599.00 and is a firm fixed-price task order issued under the &quot;In Vivo Toxicology of Tobacco 2015-2020&quot; indefinite-delivery, indefinite-quantity (IDIQ) contract. The...

Westat, Inc. was awarded a definitive cost-plus-fixed-fee prime contract by the National Institutes of Health National Cancer Institute valued at up to four hundred thirteen million, six hundred twenty-five thousand, four hundred thirty-four dollars and eighty-eight cents ($413,625,434.88) to serve as the Study Coordinating and Data Management Center for the TAS::75 0849::TAS PROSTATE, LUNG, COLORECTAL, AND OVARIAN CANCER SCREENING TRIAL from September 30, 1992 through September 29, 2015. The...

This is a firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Charles River Laboratories, Inc. for the Endoscan-V software upgrade to version 6. The contract has a ceiling value of $11,049.00 and a period of performance through September 17, 2025. The software upgrade is being procured through a sole source contract under NAICS code 334516. No set-aside designation was used. Charles River Laboratories is a global contract research organization that...

This is a federal contract award from the National Cancer Institute (NCI), a civilian agency, to Ventana Medical Systems, Inc., a foreign-owned for-profit manufacturer. The award is for the delivery of a TAS::75 0849::TASULTRA VIEW DETECTION KIT HARRIS; VENTANA, with a firm fixed-price ceiling value of $11,316.95 and a completion date of April 29, 2010. The contract has no set-aside designation. This appears to be a one-time delivery order and is not associated with a larger contract vehicle.

This is a cost-plus-fixed-fee delivery order contract awarded by the National Cancer Institute (NCI), a civilian agency, to the University of Illinois. The contract is valued at $761,043.02 and is part of the larger &quot;Toxicology of Drugs Developed for Cancer Patients&quot; indefinite delivery/indefinite quantity (IDIQ) contract vehicle. The purpose of this award is to conduct pre-clinical toxicology studies of a drug candidate, specifically DNA methyltransferase-TdCyd, for potential use in...

<p>This is a Small Business Innovation Research (SBIR) Phase I award from the National Cancer Institute (NCI), a civilian agency, to Santech, Inc. The contract is for the development of TAS (Technology for Automated Storage, Analysis, and Reporting) systems for objective behavioral exposures. The contract has a firm fixed price of $197,233.00 and was awarded on September 23, 2011, with an ultimate completion date of June 22, 2012.</p>

This is a $109,853.26 firm fixed price purchase order awarded by the National Institute on Drug Abuse, a component of the U.S. Department of Health and Human Services, to Clarivate Analytics (Us) LLC. The contract provides a user license and subscription to the OFF-X (Translational Safety/Toxicology) and Cortellis Drug Discovery Intelligence software with the Biomarkers Module for the period of April 1, 2024 through March 31, 2025, with a total contract period of performance through March 31,...